A Study on the Synthesis of Risedronic Acid: The Role of an Ionic liquid Additive

被引:6
作者
Nagy, David Illes [1 ]
Grun, Alajos [1 ]
Sinkovicz, Julia [1 ]
Garadnay, Sandor [2 ]
Greiner, Istvan [2 ]
Keglevich, Gyorgy [1 ]
机构
[1] Budapest Univ Technol & Econ, Dept Organ Chem & Technol, H-1521 Budapest, Hungary
[2] Gedeon Richter Plc, H-1475 Budapest, Hungary
关键词
Risedronic acid; 3-pyridylacetic acid; P-reagents; sulfolane; ionic liquid additive; optimization; HETEROCYCLIC DRONIC ACIDS; EFFICIENT SYNTHESIS; ZOLEDRONIC ACID; BISPHOSPHONATES; NITROGEN;
D O I
10.2174/1570180815666180626122630
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The synthesis of high value risedronic acid is not fully resolved, as, for the time being, the best method based on the preparation from 3-pyridylcarboxylic acid by reaction with phosphorus trichloride in methanesulfonic acid gives risedronic acid in a good yield, but in an unpure form. Methods: Alternative protocols realizing the synthesis in sulfolane as the solvent and/or in the presence of suitable IL additive were developed to obtain the target dronic acid in a pure form. Results & Conclusion: Using phosphorus trichloride and phosphorous acid in two equivalents quantities together with 0.6 equivalents of [bmim][BF4] without any solvent, the method afforded the target dronic acid in a yield of 66% in a pure form.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 42 条
[1]  
Balasubramaniam R., 2009, WO, Patent No. [2009/ 34580, 2009]
[2]  
Bhimavarapu S. R., 2008, WO, Patent No. [2009/ 3001, 2009]
[3]  
Boissier S, 2000, CANCER RES, V60, P2949
[4]  
Cazer F., 2001, US, Patent No. [2001/ 041690, 2001]
[5]  
Chhipa N. M. R., 2013, INT J DRUG DEV RES, V5, P120
[6]   Risedronate -: A clinical review [J].
Crandall, C .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :353-360
[7]  
Danda S. R., 2007, US, Patent No. [2007/ 173645, 2007]
[8]  
DeFerra L., 2003, WO, Patent No. [2003/ 093282, 2003]
[9]  
Deshpande P. B., 2006, US, Patent No. 7439385
[10]  
Grassi S., 2005, WO, Patent No. [2005/ 63779, 2005]